AcuCort AB Statistics
Total Valuation
AcuCort AB has a market cap or net worth of SEK 166.92 million. The enterprise value is 145.77 million.
| Market Cap | 166.92M |
| Enterprise Value | 145.77M |
Important Dates
The last earnings date was Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AcuCort AB has 234.44 million shares outstanding.
| Current Share Class | 234.44M |
| Shares Outstanding | 234.44M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | -0.82% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.45 |
| PB Ratio | 2.93 |
| P/TBV Ratio | 3.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.50 |
| EV / Sales | 19.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.31
| Current Ratio | 4.31 |
| Quick Ratio | 4.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -267.83 |
Financial Efficiency
Return on equity (ROE) is -39.37% and return on invested capital (ROIC) is -24.87%.
| Return on Equity (ROE) | -39.37% |
| Return on Assets (ROA) | -23.40% |
| Return on Invested Capital (ROIC) | -24.87% |
| Return on Capital Employed (ROCE) | -47.06% |
| Weighted Average Cost of Capital (WACC) | 11.84% |
| Revenue Per Employee | 1.49M |
| Profits Per Employee | -5.30M |
| Employee Count | 5 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.36% in the last 52 weeks. The beta is 1.38, so AcuCort AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -22.36% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 49.90 |
| Average Volume (20 Days) | 367,599 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AcuCort AB had revenue of SEK 7.44 million and -26.50 million in losses. Loss per share was -0.12.
| Revenue | 7.44M |
| Gross Profit | -13.48M |
| Operating Income | -26.78M |
| Pretax Income | -26.50M |
| Net Income | -26.50M |
| EBITDA | -18.56M |
| EBIT | -26.78M |
| Loss Per Share | -0.12 |
Balance Sheet
The company has 21.15 million in cash and n/a in debt, with a net cash position of 21.15 million or 0.09 per share.
| Cash & Cash Equivalents | 21.15M |
| Total Debt | n/a |
| Net Cash | 21.15M |
| Net Cash Per Share | 0.09 |
| Equity (Book Value) | 56.91M |
| Book Value Per Share | 0.24 |
| Working Capital | 17.54M |
Cash Flow
| Operating Cash Flow | -16.17M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 8.10M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -181.22% |
| Operating Margin | -360.13% |
| Pretax Margin | -356.34% |
| Profit Margin | n/a |
| EBITDA Margin | -249.56% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AcuCort AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -15.88% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AcuCort AB has an Altman Z-Score of 13.86 and a Piotroski F-Score of 1.
| Altman Z-Score | 13.86 |
| Piotroski F-Score | 1 |